|
Semaglutide Injectable Product Clinical Trials
4 actively recruiting trials across 1 location
Also known as: Ozempic
Other3 trials
San Antonio, Texas1 trial
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
University Health - Texas Diabetic Institute
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.